Business Type: Manufacturer, Trading Company, Buying Office, Agent, Distributor/Wholesaler, Government ministry/Bureau/Commission, Association, Business Service (Transportation, finance, travel, Ads, etc), Other
Employees Total
Annual Revenue
Keytruda (pembrolizumab) is a member of the anti-PD-1 monoclonal antibodies drug class and is commonly used for Breast Cancer, Cervical Cancer, Colorectal Cancer, and others.